Crinetics Pharmaceuticals Inc (CRNX) earnings · rev $7.7M
These earnings events as JSON? API free 100/dayCrinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
This CRNX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. Revenue was up 640.7% from 2024-12-31 to 2025-12-31. CRNX currently screens at market cap $2.76B.
When the next CRNX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 640.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CRNX research stays on the stock page; the tape stays on the quote page.
CRNX earnings FAQ
What are CRNX's latest revenue and net income?
Latest cached Crinetics Pharmaceuticals Inc (CRNX) revenue for Dec 31, 2025 was $7.7M. Net income was -$465.3M. Statements: https://lician.com/financials/crnx
What is CRNX's latest diluted EPS?
Latest cached Crinetics Pharmaceuticals Inc (CRNX) diluted EPS for Dec 31, 2025 was -$4.95.
What period does the latest CRNX earnings print cover?
The latest cached Crinetics Pharmaceuticals Inc (CRNX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CRNX revenue change from the prior cached period?
Cached Crinetics Pharmaceuticals Inc (CRNX) revenue was up 640.7% from $1.0M (Dec 31, 2024) to $7.7M (Dec 31, 2025). Statements: https://lician.com/financials/crnx
Where are CRNX earnings listed?
Cached earnings facts for Crinetics Pharmaceuticals Inc (CRNX) are listed at https://lician.com/earnings/crnx. Statements: https://lician.com/financials/crnx
Not investment advice.